Two prostate-specific antigens are being explored in Phase I trials in prostate cancer thus far using PSMA and prostate stem cell antigen (PSCA), which is primarily expressed in prostate cancer cells and is expressed in advanced prostate cancer [81]. This evidence concerns the gene PSCA and prostate cancer.